Our group uses proteomics in combination with other -omics technologies, such as metabolomics, lipidomics and microRNA profiling, to integrate biological information in disease-specific networks that drive pathopysiological changes. While studying molecular interactions has been a research focus for many years and has provided important insight into biology, the attention has now shifted towards a more integrative network biology approach.
British Heart Foundation
Queen Mary University of London
University of Oxford
MUI, Medizinischen Universität Innsbruck
University Medicine Göttingen
British Heart Foundation Professor of Cardiovascular Proteomics
Manuel Mayr - Professor of Cardiovascular Proteomics